Literature DB >> 15093563

Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease.

Sílvia de Barros-Mazon1, Maria E Guariento, Cleide Aparecida da Silva, Robert L Coffman, Ises A Abrahamsohn.   

Abstract

In the search to identify differences in the immunological response between patients with the indeterminate or cardiac form of Chagas disease, trypomastigote-specific peripheral blood mononuclear cell (PBMC) proliferative responses were studied. Suppression of lymphoproliferation occurred in both groups of patients, being more intense in those with the cardiac form. By adding to the cultures neutralizing mAbs anti-IFN-gamma, anti-IL-4, anti-IL-13, or anti-IL-10, indomethacin to block prostaglandin synthesis, NMMA as inhibitor of nitric oxide (NO) synthesis, or glutathione-peroxidase as H(2)O(2) scavenger, it was found that indomethacin augmented lymphoproliferation in both groups of patients. However, anti-IL-10 treatment increased proliferation only in PBMC cultures from patients with the cardiac form, indicating that in these patients, IL-10 was suppressing the immune response. These patients also had higher IL-10 levels in unstimulated cultures and higher PGE(2) levels in stimulated cultures. The results evidence that IL-10 regulates parasite-specific T cell responses in patients with the cardiac form, whereas regulation by prostaglandins (PG) occurs in patients with either cardiac or indeterminate form of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093563     DOI: 10.1016/j.clim.2004.01.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

Review 1.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

Review 2.  Bioactive lipids in Trypanosoma cruzi infection.

Authors:  Fabiana S Machado; Shankar Mukherjee; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

3.  Expression of cytokines and chemokines and microvasculature alterations of the tongue from patients with chronic Chagas' disease.

Authors:  Sanivia A de Lima Pereira; Viviane O Severino; Narayane L M Kohl; Denise B R Rodrigues; Polyanna M Alves; Juliana T Clemente-Napimoga; Marlene A dos Reis; Vicente P A Teixeira; Marcelo H Napimoga
Journal:  Parasitol Res       Date:  2009-06-10       Impact factor: 2.289

4.  Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.

Authors:  Virginia M B Lorena; Alinne F A Verçosa; Raquel C A Machado; Lucas Moitinho-Silva; Maria G A Cavalcanti; Edimilson D Silva; Antonio G P Ferreira; Rodrigo Correa-Oliveira; Valéria R A Pereira; Yara M Gomes
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

5.  Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi.

Authors:  Suellen Carvalho de Moura Braz; Adriene Siqueira de Melo; Maria da Glória Aureliano de Melo Cavalcanti; Sílvia Marinho Martins; Wilson de Oliveira; Edimilson Domingos da Silva; Antonio Gomes Pinto Ferreira; Virginia Maria Barros de Lorena; Yara de Miranda Gomes
Journal:  J Clin Immunol       Date:  2014-09-10       Impact factor: 8.317

Review 6.  Regulatory T cells phenotype in different clinical forms of Chagas' disease.

Authors:  Fernanda Fortes de Araújo; Danielle Marquete Vitelli-Avelar; Andréa Teixeira-Carvalho; Paulo Renato Antas; Juliana Assis Silva Gomes; Renato Sathler-Avelar; Manoel Otávio Costa Rocha; Silvana Maria Elói-Santos; Rosa Teixeira Pinho; Rodrigo Correa-Oliveira; Olindo Assis Martins-Filho
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

7.  Cytokine production but lack of proliferation in peripheral blood mononuclear cells from chronic Chagas' disease cardiomyopathy patients in response to T. cruzi ribosomal P proteins.

Authors:  Silvia A Longhi; Augusto Atienza; Graciela Perez Prados; Alcinette Buying; Virginia Balouz; Carlos A Buscaglia; Radleigh Santos; Laura M Tasso; Ricardo Bonato; Pablo Chiale; Clemencia Pinilla; Valeria A Judkowski; Karina A Gómez
Journal:  PLoS Negl Trop Dis       Date:  2014-06-05

8.  Role of T. cruzi exposure in the pattern of T cell cytokines among chronically infected HIV and Chagas disease patients.

Authors:  Tania Regina Tozetto-Mendoza; Dewton de Moraes Vasconcelos; Karim Yaqub Ibrahim; Ana Marli Christovam Sartori; Rita C Bezerra; Vera Lúcia Teixeira de Freitas; Maria Aparecida Shikanai-Yasuda
Journal:  Clinics (Sao Paulo)       Date:  2017-11       Impact factor: 2.365

9.  Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection.

Authors:  Néstor A Guerrero; Mercedes Camacho; Luis Vila; Miguel A Íñiguez; Carlos Chillón-Marinas; Henar Cuervo; Cristina Poveda; Manuel Fresno; Núria Gironès
Journal:  PLoS Negl Trop Dis       Date:  2015-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.